PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

WHO names the main causes of mortality among Russians

The majority of deaths in Russia are caused by cardiovascular diseases and related conditions.

More than 80% of deaths in the country are linked to cardiovascular diseases, malignant neoplasms, chronic respiratory illnesses, and diabetes, said Batyr Berdyklychev, head of the World Health Organization (WHO) office in Moscow, in an interview with RIA Novosti.

“The main disease burden is primarily associated with chronic non-communicable diseases such as cardiovascular diseases, malignant neoplasms, chronic respiratory diseases, and diabetes. These conditions account for more than 80% of all deaths in the country,” he noted.

Berdyklychev added that factors influencing morbidity and mortality include alcohol abuse, smoking, excessive salt consumption, unhealthy diets, air pollution, and high blood pressure.

According to Rosstat data, Russia’s natural population decline (the excess of deaths over births) reached nearly 597,000 people in 2024. The number of births stood at 1.222 million, lower than in 2023, while deaths rose to 1.82 million. The record decline in modern history was registered in 2021 during the COVID-19 pandemic, when it exceeded 1 million people.

In August 2025, Roman Gorenkov, chief specialist in general medical practice at the Moscow Region’s Ministry of Health, cited similar mortality causes, adding tuberculosis, HIV, and mental disorders to the list.

The WHO representative also assessed Russia’s targets for life expectancy: 78 years by 2031 and 81 years by 2036. He recalled that progress has already been made since the start of the century: from 65 years in 2000 to 73 years in 2019. Although the pandemic temporarily stalled growth, “this progress reflects the results of systemic work in healthcare, social development, and quality of life improvement.” The targets are “ambitious but realistic,” Berdyklychev concluded.

Source: RBC, 20.09.2025

Current news

  • November 5, 2025

    Takeda Finds Buyer for Its Yaroslavl Manufacturing Facility

    Japanese pharmaceutical company Takeda has received approval from the Russian Government Commission for Control over…

  • November 5, 2025

    What Pharmaceutical Sovereignty Will Look Like in Russia

    The development of a full-cycle pharmaceutical industry in Russia is seen as the key to…

  • November 5, 2025

    Crystalline DNA “Flowers” Created for Targeted Drug Delivery

    They can unfold and fold up to ten times, enabling multiple uses. American chemists have…

  • November 5, 2025

    Healthy Lifestyle vs. “Magic Pills”: How Russia Is Working to Extend Life Expectancy

    Russia’s Minister of Health, Mikhail Murashko, has called for a reconsideration of traditional views on…

  • November 5, 2025

    Russian Health Ministry Estimates Share of Domestic Medicines at 70% by Number of Packages

    The ratio of Russian to foreign medicines in the pharmaceutical market by the number of…

LLC “BioJet”. all rights reserved

  • Legal information